![Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2 | Nature Communications Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2 | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-16966-3/MediaObjects/41467_2020_16966_Fig1_HTML.png)
Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2 | Nature Communications
![Tumor- and metastasis-promoting roles of miR-488 inhibition via HULC enhancement and EZH2-mediated p53 repression in gastric cancer | SpringerLink Tumor- and metastasis-promoting roles of miR-488 inhibition via HULC enhancement and EZH2-mediated p53 repression in gastric cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10565-022-09760-y/MediaObjects/10565_2022_9760_Figa_HTML.png)
Tumor- and metastasis-promoting roles of miR-488 inhibition via HULC enhancement and EZH2-mediated p53 repression in gastric cancer | SpringerLink
![HULC targets the IGF1R–PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance - ScienceDirect HULC targets the IGF1R–PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304383522003457-gr2.jpg)
HULC targets the IGF1R–PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance - ScienceDirect
![HULC targets the IGF1R–PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance - ScienceDirect HULC targets the IGF1R–PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304383522003457-gr1.jpg)